April 23, 2020—Randox Laboratories has developed Randox Qnostics SARS-CoV-2 whole pathogen quality controls designed for laboratories managing COVID-19 testing to help ensure the accuracy and reliability of molecular assays used in the testing of suspected coronavirus samples.
The controls contain the entire SARS-CoV-2 genome, the company said in a press release, including the conserved regions recommended by the Centers for Disease Control and Prevention and World Health Organization. They are compatible for use with commercial and in-house testing methods and are quantified by digital PCR to ensure batch-to-batch reproducibility. The controls are heat-inactivated to be noninfectious, manufactured to ISO 13485 standards, and supplied in a liquid frozen format.